What is the approximate latest market price of Nirapali, abiraterone tablets?
Niraparib, abiraterone tablets (Akeega) is a new anti-tumor drug mainly used to treat certain types of advanced cancer, especially prostate cancer. The drug is composed of two ingredients: abiraterone and niraparib. It inhibits the synthesis of androgens and blocks the DNA repair mechanism to achieve the effect of inhibiting tumor growth. In recent years, with the continuous exploration of treatment methods for prostate cancer, niraparib and abiraterone tablets have gradually attracted attention and demonstrated good clinical efficacy.

In China, niraparib and abiraterone tablets have been approved for marketing. However, due to its short time on the market, specific information on its price, medical insurance coverage, etc. is still unclear. This puts patients at risk of facing a financial burden when receiving treatment. According to the current market conditions, the common specifications of overseas original research are (500mg/50mg) * 60 tablets and (500mg/100mg) * 60 tablets. Each box is sold for more than 20,000 yuan. The specific price will fluctuate due to different regions and market factors. This high price undoubtedly poses a challenge for some patients, especially if long-term medication is required. It is worth noting that there are currently no generic drugs of niraparib and abiraterone tablets on the overseas market, which means that patients can only rely on the original drug for treatment.
Even though niraparibabiraterone tablets are on the market in China, due to its unique dual mechanism of action, it occupies an important position in the selection of therapeutic drugs. Doctors can develop personalized treatment plans based on the patient's specific condition. Especially for patients with drug-resistant or recurrent prostate cancer, niraparib and abiraterone tablets provide a new treatment option. In clinical application, doctors need to pay close attention to patients' drug reactions and side effects to ensure the safety and effectiveness of treatment.
Reference materials:https://www.drugs.com/akeega.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)